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DOPC versus DOPE as a helper lipid for
gene-therapies: molecular dynamics
simulations with DLin-MC3-DMA†
Inna Ermilova * and Jan Swenson
Ionizable lipids are important compounds of modern therapeutic lipid nano-particles (LNPs). One of the
most promising ionizable lipids (or amine lipids) is DLin-MC3-DMA. Depending on their pharmaceutical
application these LNPs can also contain various helper lipids, such as phospho- and pegylated lipids,
cholesterol and nucleic acids as a cargo. Due to their complex compositions the structures of these
therapeutics have not been refined properly. Therefore, the role of each lipid in the pharmacological
properties of LNPs has not been determined. In this work an atomistic model for the neutral form of
DLin-MC3-DMA was derived and all-atom molecular dynamics (MD) simulations were carried out in order to
investigate the effect of the phospholipid headgroup on the possible properties of the shell-membranes of
LNPs. Bilayers containing either DOPC or DOPE lipids at two different ratios of DLin-MC3-DMA (5 mol% and
15 mol%) were constructed and simulated at neutral pH 7.4. The results from the analysis of MD trajectories
revealed that DOPE lipid headgroups associated strongly with lipid tails and carbonyl oxygens of DLin-MC3-
DMA, while for DOPC lipid headgroups no significant associations were observed. Furthermore, the strong
associations between DOPE and DLin-MC3-DMA result in the positioning of DLin-MC3-DMA at the surface
of the membrane. Such an interplay between the lipids slows down the lateral diffusion of all simulated
bilayers, where a more dramatic decrease of the diffusion rate is observed in membranes with DOPE. This
can explain the low water penetration of lipid bilayers with phosphatidylethanolamines and, probably, can
relate to the bad transfection properties of LNPs with DOPE and DLin-MC3-DMA.
1 Introduction
Modern gene-therapies are widely using lipid-nanoparticles
(LNPs) as vehicles for the delivery of nucleic acids. These LNPs
can be employed for curing a large range of diseases, such as
cancer,1,2 amyloidosis,3 Alzheimer’s disease,4 Ebola,5 modern
coronavirus COVID-196,7 and many others. Depending on
their applications, these LNPs can contain phospholipids,
cholesterol, pegylated lipids, ionizable lipids and a cargo (a
nucleic acid).8,9 Such a variety of components leads to complex
structures of large sizes. These complex structures are very
challenging to elucidate by experiments, such as X-ray and
neutron diffraction, and cryogenic transmission electron
microscopy (cryo-TEM). The obstacle here is the polydispersity
of therapeutics, which can be seen in the variety of sizes of
LNPs10 in the same mixture and in the diversity of textures
within a single particle.11 Typically, the experimental studies
have to be combined with structural modelling,12,13 despite the
computational limits, in order to refine the texture of the LNPs
on an atomistic level and reveal the exact mechanisms behind
the pharmacological properties of therapeutics.
There were attempts to come closer to understanding these
mechanisms by creating LNPs where one component was
selected to be a variable. Comparative experimental studies were
performed using formulations with changes of either a phospho-
lipid (so-called ‘‘helper lipid’’14,15) or an ionizable lipid.
In one of such studies Kulkarni et al.16 have investigated
LNPs for plasmid DNA delivery using various phospholipids
(DOPE, DOPC, SOPC, and DSPC) as well as ionizable lipids,
cholesterol and pegylated lipids. The ratio between the
compounds was the same. The in vitro studies showed that
LNPs containing DOPE as a helper lipid were more potent in a
sense of transfection properties when the ionizable lipid was
DLin-KC2-DMA. In the same study when the ionizable lipid was
DLin-MC3-DMA the best helper lipids were DOPC and SOPC16
and DOPE exhibited the worst transfection properties.
For the siRNA encapsulation together with DLin-KC2-DMA
the best phospholipid was DSPC, according to Kulkarni et al.17
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However, there were no experiments in their work showing the
efficacy of LNPs in the sense of transfection.
Jayaraman et al.18 have performed a more detailed study
where they compared 56 ionizable lipids as compounds of siRNA
LNPs: DLin-MC3-DMA exhibited the best gene-silencing activity in
formulations containing DSPC, cholesterol and pegylated lipids.
In 2018 the first siRNA based drug, produced by Alnylam for
curing amyloidosis, was approved.19–21 This became a game-
changer in the pharmaceutical industry in the race for RNA-
based vaccines.21 This drug contains DLin-MC3-DMA. The most
potent ionizable lipid became very attractive for other pharma-
ceutical companies which are working on developing mRNA
vaccines.22,23
Nevertheless, even for the approved new drug, the precise
mechanisms of interactions between DLin-MC3-DMA and var-
ious phospholipids and the structure of the therapeutic were
not disclosed. The lack of this information made medicines for
gene-therapies attractive for computational studies.
A small number of theoretical studies have been done with
DLin-KC2-DMA, but no computational study has been per-
formed with DLin-MC3-DMA, probably, due to the absence of
numerical models. Ramenzapour et al.24 combined MD simula-
tions with cryo-TEM and SAXS for investigating membranes,
formed by POPC, cholesterol and the ionizable lipid, at acidic
and neutral pH. According to their study, whole molecules of
DLin-KC2-DMA preferred to reside in the center of the lipid
bilayer at pH 7.4 while at higher pH the ionizable lipids were
positioned with headgroups towards the membrane surface
and their tails were spread between the tails of POPC.24
Leung et al.25 went towards the lower resolution in computer
simulations by carrying out coarse-grained (CG) simulations of
whole LNPs and combining them with 31P NMR and cryo-TEM
techniques. Their vehicles contained DLin-KC2-DMA, siRNA
duplexes, DSPC, cholesterol and pegylated lipid. The images
obtained from snapshots from CG simulations were quite
similar to the cryo-TEM images. However, the mechanisms
behind phase formation and intermolecular interactions were
not disclosed due to the low resolution of the CG simulations.
In this theoretical work, we are beginning to employ the
multiscale simulation approach26–28 by starting from simple
systems and atomistic MD simulations with the derivation of
the numerical model for one of the most potent ionizable
lipids, which will help us to derive CG models in future. The
primary attention is focused on understanding the mechan-
isms behind interactions between different phospholipids and
DLin-MC3-DMA. Four model membranes containing various
amounts of DLin-MC3-DMA (Fig. 1(a)) and DOPC and DOPE
lipids (Fig. 1(c) and (d)) at neutral pH serve as possible pieces of
LNP shells. The reason for the selection of the specific phos-
pholipids was to compare the behavior of DLin-MC3-DMA in
membranes built of lipids containing identical tails, but differ-
ent headgroups. This can unveil possible reasons of efficacies
of LNPs. For instance, from MD trajectories one can calculate
mass density profiles for whole systems and for different parts
of the molecules. This determines the partitioning of molecules
in lipid bilayers, including the water permeabilities of mem-
branes. Computed lateral diffusion coefficients give an idea
of the molecular velocities in planes parallel to membrane
surfaces. Radial distribution functions (RDFs) demonstrate
associations between pairs of atoms, indicate the possible
formation of hydrogen bonds and, perhaps, reveal the mechan-
isms of interactions between the lipids.
Moreover, free energy calculations with well-tempered
metadynamics29–31 simulations are employed for the investiga-
tion of water penetration through four studied model mem-
branes. A thermodynamic characteristic of this process, such as
free energy (DG1), is known to indicate if the process can
proceed spontaneously (DG1o 0). A comparison between the
binding free energy values will reveal which membrane is
more permeable. For such studies well-tempered metadynamics
Fig. 1 Lipids which were used in MD simulations. (a) DLin-MC3-DMA. (b) The part of DLin-MC3-DMA which was used for the FF parametrization. (c)
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simulations are considered as the most promising approach32
due to its ability to sample only ‘‘interesting’’ parts of free
energy landscape. Therefore, the information about the bind-
ing free energies of water to membranes can shed light on the
efficacy of LNPs containing in their outer shells DLin-MC3-
DMA with either DOPC or DOPE lipids.
2 Models and simulation setup
Parametrization of the model for DLin-MC3-DMA
The model for DLin-MC3-DMA was developed by applying the
same philosophy as was done in the case of polyunsaturated
phospholipids.34 Since the pH around an LNP is considered as
neutral, a neutral model for the ionizable lipid was derived and
the total molecular charge was set to zero. Since we will not use
the ionized form of this compound, we will call it the ‘‘amine’’
lipid until the end of this paper.
The strategy for the derivation of parameters was the same
as the one used in previous versions of the SLipids force field
(FF)34–36 for polyunsaturated phospholipids. The general form
of the SLipids FF can be written as:
EFF = Ebonded + Enon-bonded, (1)
where
Ebonded = Eangles + Edihedrals + Ebonds + EUrey–Bradley
(2)
and
Enon-bonded = ELennard-Jones + ECoulomb. (3)
In this work the accent was on calculations of partial atomic
charges and parameters for dihedrals for the headgroup of
DLin-MC3-DMA, while the partial charges for the lipid tails
were slightly adjusted from the ones which were derived in the
earlier version of the SLipids FF.34 Dihedrals for the DLin-MC3-DMA
tails were taken from the SLipids FF for polyunsaturated lipids.34
Since quantum chemical calculations have high costs in
terms of computational time and computer memory,37,38 the
smaller model compound for DLin-MC3-DMA was utilized
(Fig. 1(b)). 50 random conformations were generated for this
molecule. Then the computations of partial atomic charges
were carried out using the B3LYP39–41 level of theory with the
basis set cc-pVTZ42 in Gaussian09 software43 together with the
restrained electrostatic potential approach (RESP)44 in the
R.E.D. software.45 The lipid headgroups were placed in a
polarizable continuum with a dielectric constant of 78.4 in
the IEFPCM model46,47 in order to mimic the solvent effects
and their induced polarization on the charge distribution. The final
set of partial atomic charges can be found in Fig. S1 of the ESI.†
After computations of partial atomic charges a set of new
parameters for dihedrals was derived using the same philoso-
phy as in the previous version of the SLipids FF.34
Fig. S2 in the ESI† illustrates the dihedrals which were
chosen for the parametrization. For the parametrization of
the dihedrals the molecule from Fig. 1(b) was used as well. As
in the SLipids FF for polyunsaturated lipids, the original
molecule was optimized using the second order Møller–Plesset
perturbation theory48 with the cc-pVDZ basis set.42 Then
conformations were created for every value of the dihedral by
rotating the optimized molecule around the dihedral of interest
with a step of 10 degrees in the interval from 180 to 180
degrees, keeping other degrees of freedom frozen. For comput-
ing the relative quantum mechanical energies of different
conformations the hybrid method for interaction energies
(HM-IE)49 was employed which was expressed by relation (4):
ECCSD(T)/BBS = ECCSD(T)/SBS + ECCSD(T)/BBS  ECCSD(T)(SBS)
E ECCSD(T)/SBS + EMP2/BBS  EMP2/SBS (4)
where MP2 denotes the second order Møller–Plesset perturba-
tion theory,48 CCSD(T) is the Coupled Cluster single-double and
perturbative triple excitation method50 from the Coupled Clus-
ter theory, SBS denotes the small basis set (cc-pVDZ),42 and BBS
denotes the big basis set (cc-pVQZ).42
After completing the high order quantum chemical calcula-
tions the resulting values were used for fitting the dihedral
potential with equation (5):
Edihedral = (ECCSD(T)/BBS  EMD)  (ECCSD(T)/BBS  EMD)min
(5)
here EMD denotes the value of the potential energy which was
computed by MD software with parameters for the dihedral of
interest set to zero. The threshold for the fitting of dihedrals
was approximately 2 kJ mol1. The illustration of dihedrals and
the results of their fitting are presented in Fig. S2 and S3 (ESI†),
respectively, and the FF parameters for the dihedrals can be
observed in Tables S1–S4 of the ESI.† During the tuning of
parameters for the dihedral NL–CL2 –CL2–CTL2 ‘‘unphysical’’
points, causing overlaps between atoms and bonds, were
removed from the data set (Fig. S3(b) in the ESI†). Furthermore,
the dihedral potentials derived in this work were computed
for new atom types of cationic lipids and CTL6, NL, and CL2
were added to the FF. Other FF parameters such as the ones
for bonds, missing values for dihedrals, and Urey–Bradley
and angular parameters were inherited from ‘‘old’’ atom types
(CTL5, NH3L, and CTL2) of the SLipids FF34–36 and the
CHARMM36 FF.51–53
MD simulation set-ups
Compositions of simulated systems are presented in Table 1.
Firstly, two lipid bilayers were created, where one was contain-
ing only DOPC and the other one was built by only DOPE lipids.
Every bilayer was built out of 100 single boxes containing two
phospholipids: one was in the outright position and the other
one was inverted (but not mirrored). The resulting bilayers
were utilized for creating membranes with various contents of
DLin-MC3-DMA. In these lipid bilayers in selected places (at a
distance of B10 Å) phospholipids were deleted and optimized
molecules of DLin-MC3-DMA were inserted instead of them.
Then every created system was equilibrated for 300 ns in the
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of 1 atm during simulations was supported by a semi-isotropic
pressure coupling scheme using the Berendsen barostat.55 The
temperature was held at 298 K by the velocity rescaling
thermostat.56 The algorithm employed for the integration of
the Newtonian equation of motion was leap-frog57 with a time
step of 2 fs and a Verlet cut-off scheme58 with the van der Waals
type cut-off and a cut-off radius of 1.2 nm. Bonds were con-
strained using the LINCS algorithm59,60 with 12 iterations. MD
simulations and analysis of the resulting trajectories were done
using built-in routines in gromacs-4.6.7 software.61 Systems
containing pure DOPC and DOPE lipid bilayers were simulated
for the sake of comparison. The generalized snapshots from
starting configurations for systems with 5 and 15% of DLin-
MC3-DMA can be observed in Fig. S4 in the ESI.† Placing
phospholipids instead of the amine lipids will give an idea
about starting configurations for systems containing only
DOPC/DOPE lipids and water.
Well-tempered metadynamics simulation set-ups
4 systems, containing DLin-MC3-DMA, were utilized for well-
tempered metadynamics29,62 simulations from previously equi-
librated classical MD simulations. For every lipid bilayer 5
different starting configurations were created where the selected
water molecule was located in various parts of the system. Later
those configurations were used for performing 5 parallel well-
tempered metadynamics simulations per lipid bilayer.63
The collective variable (CV) was chosen as the Z-component
of the distance between the centers of mass of the water
molecule and a lipid bilayer (see Fig. 2). The Gaussian functions
were of height 1.2 kJ mol1. Their width was 0.05 nm (the
parameter s) which were deposited every 500 steps (the value of
the parameter PACE). Due to the small size of the water
molecule, the bias factor, g, was set to 10.0.
All simulations were performed in the NVT ensemble at a
temperature of 298 K using the velocity rescaling thermostat.56
The integrator for Newtonian equations of motions was leap-frog57
with a time step of 2 fs and a cut-off scheme Verlet58 where a cutoff
radius was 1.2 nm. The LINCS algorithm was employed for
constraining bonds with 12 iterations.59,60 The software used as
an MD engine was gromacs-4.6.7 with plumed-2.1.262 for the free
energy calculation. Every simulation was carried out for 150 ns.
3 Results and discussion
Fig. 3 shows final snapshots of the simulated systems. In (a)
and (b) no significant differences can be observed in the
positioning of DLin-MC3-DMA in DOPC and DOPE membranes
respectively: the amine lipids are situated close to the surfaces
of the bilayers. Fig. 3(c) and (d) present systems with lower
contents of phospholipids. In this case DLin-MC3-DMA exhi-
bits a preference to be located at the surface of the membrane
with DOPE while in the case of DOPC the amine lipid is
partitioned in the center of the bilayer to a large extent.
Fig. 3 shows also that the amine lipid tends to cluster in all
simulated systems.
The analysis of snapshots is important, but it does not give
the information about the statistics over the whole simulation
time. That is why more detailed analysis of trajectories was
carried out.
3.1 Lateral diffusion, average area per lipid, and mass density
profiles
The lateral diffusion coefficient is one of the key characteristics
of a lipid bilayer.64,65 It can determine how fast lipids move in two
dimensions, and give an idea about the viscosity of membranes64








DOPC 190 10 8000
DOPC 170 30 8000
DOPE 190 10 8000
DOPE 170 30 8000
DOPC (pure) 200 0 8000
DOPE (pure) 200 0 8000
Fig. 2 Definition of the collective variable for well-tempered metadynamics simulations. A small red molecule is a water molecule, cyan molecules are
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and their fluidity.66–68 The membrane fluidity and its fusogenicity
have an impact on a drug delivery process.69
Table 2 shows lateral diffusion coefficients for the investi-
gated systems, which were computed using a correction for
the artificial center of mass motion of each monolayer as it
was done earlier by Jämbeck et al.35 The experimental lateral
diffusion coefficient at a temperature of 298 K was available
only for the pure DOPC lipid bilayer, which was about 0.932 
107 cm2 s1 71 and comparable with our computed value.
Nevertheless, regardless of such a good agreement with experi-
ment it is important to note that the computed values are
sensitive to the box shape and can have an error of up to 50%
due to the artifacts from periodic boundary conditions accord-
ing to B. A. Camley et al.72 and R. M. Venable et al.73 Taking
into account this fact we can try to compare the results for
simulations with the amine lipid.
In systems containing DOPC the diffusion of phosphatidyl-
choline as well as the diffusion of the amine lipid slows
down when the amount of DLin-MC3-DMA increases. An even
stronger effect is observed in systems with DOPE, where the
addition of DLin-MC3-DMA decreases the diffusion of both
lipids more dramatically than in the case of membranes with
DOPC. This can be considered as a reason for why LNPs
containing DLin-MC3-DMA and DOPE do not exhibit good
transfection in plasmid DNA delivery, because in the process
of the DNA delivery16 the lateral diffusion and the membrane
fusion are important factors.
However, the lateral diffusion is a consequence of intra-
and intermolecular interactions.74,75 Therefore, the differences
in diffusion indicate that there may be strong associations
between DOPE headgroups and DLin-MC3-DMA. For checking
up this assumption one can calculate other properties of
simulated membranes.
One such property is the area per lipid.76,77 In every system
there were 100 lipids per leaflet. According to this number of lipids
the average area per lipid was calculated for each membrane by
dividing the area of the simulation box in a plane perpendicular to





where boxx and boxy are sizes of the simulation box in x- and
y-directions. Table 3 presents the values which were computed
over the last 300 ns of the simulation (production run). Accord-
ing to the table, membranes containing DOPC have higher
areas per lipid than the ones with DOPE. Upon increasing the
Fig. 3 Snapshots of the final frames of the systems: frontal views and views from the top of the box. (a) DOPC and 5% of DLin-MC3-DMA, (b) DOPE and
5% of DLin-MC3-DMA, (c) DOPC and 15% of DLin-MC3-DMA and (d) DOPE and 15% of DLin-MC3-DMA. Phospholipids are visualized by cyan color with
phosphorus shown as spheres of dark lime color. DLin-MC3-DMA is visualized by the dark blue color. The molecular graphics software is VMD.33






DOPC + 5%DLin-MC3-DMA 1.15  0.40 1.01  0.45
DOPC + 15%DLin-MC3-DMA 0.94  0.40 0.65  0.40
DOPE + 5%DLin-MC3-DMA 1.00  0.45 1.15  0.30
DOPE + 15%DLin-MC3-DMA 0.66  0.45 0.55  0.20
DOPC (pure) 0.98  0.42 —
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amount of DLin-MC3-DMA the average area per lipid grows as
well. In systems with DOPE the gain in the average area per
lipid compared to the pure membranes is higher than in
systems with DOPC. Nevertheless, the values from Table 3
are not precise for every lipid headgroup, since lipid tails of
DLin-MC3-DMA can appear at the surface and in some frames the
whole amine lipids could be located in the center of the membrane,
without appearing at the bilayer surface. The conclusion which can
be made out of values for the areas per lipids is that the
simulation boxes get wider at 15 mol% of DLin-MC3-DMA.
The calculated profiles for areas per lipid indicate the conver-
gence of MD simulation at about 300 ns and can be observed in
Fig. S5 of the ESI.†
Another property is the mass density of the lipid bilayer,
measured in the direction perpendicular to the plane of the
membrane surface. Mass density profiles are similar to electron
density profiles, which can be obtained using X-ray scattering.
The highest value of the total mass density is associated with
lipid headgroups and the lowest value shows where the bilayer
center is situated.78
Fig. 4 demonstrates mass density profiles for the simulated
systems as well as for lipid bilayers containing pure phospho-
lipids. Both (a) and (b) parts of the figure exhibit the same trend
in shifting the peak of the mass density towards the bilayer
center with increasing concentration of DLin-MC3-DMA. This
can be interpreted as thinning of the bilayer since the highest
value of mass density is associated with the position of the lipid
headgroup (see Table 3 for the computed membrane thickness
values). Nevertheless, in order to get an exact picture of where
the various parts of the lipid molecules are situated one shall
compute contributions to the mass density profiles from
those parts.
Fig. 5 displays contributions to mass density profiles from
headgroups and tails for both lipids. Already at the lowest
concentration of the amine lipid (5 mol%) differences in
profiles for the two phospholipids can be observed (Fig. 5(a)
and (b)): the position of the peak for the DLin-MC3-DMA tail is
in the DOPE headgroup region while in the case of DOPC this
peak appears in the region for the phospholipid tails. The
headgroup of the amine lipid ‘‘prefers’’ to be situated between
phospholipid headgroups in both DOPC and DOPE membranes.
When the amount of the amine lipid is 15 mol% (Fig. 5(c)
and (d)) the peak for the DLin-MC3-DMA tail is shifted to
just outside the area for the DOPE headgroup. In the DOPC
membrane the position of this peak does not change, compared
to lipid bilayers with 5 mol% of the amine lipid. Moreover, a
higher amount of the DLin-MC3-DMA tails resides in the center of
the DOPC membrane than in the lipid bilayer with DOPE. The
headgroup of the amine lipid ‘‘prefers’’ to be located in the region
of the phospholipid headgroups, but in the membrane with
DOPC a small amount was detected even in the center of the
lipid bilayer. Such a location of DLin-MC3-DMA is slightly similar
to the one which was observed by Ramenzapour et al.24 in
simulations of DLin-KC2-DMA in a membrane containing POPC
and cholesterol at a neutral pH.
However, lipids are not the only molecules present in the
simulated systems. Due to their motion the motion of water can
be affected. The water can penetrate the membranes as well.
Fig. S6 in the ESI† shows mass density profiles for water in the
simulated membranes. In pure phospholipid bilayers there
were no significant amounts of water detected in the center
of the bilayers, but the addition of the amine lipid has changed
the penetration of the membranes. For instance, the amount of
5 mol% has made the DOPE lipid membrane permeable
(Fig. S6(b), ESI†), while in the case of DOPC the penetration
was more negligible (Fig. S6(a), ESI†). At a higher concentration
of DLin-MC3-DMA (15 mol%) the situation was the other way
around and the water penetration of the bilayer containing
Table 3 Average area per lipid, Å2, and the membrane thickness, Å
System Area per lipid
The membrane
thickness
DOPC + 5%DLin-MC3-DMA 70.98  0.3 33.9  0.1
DOPC + 15%DLin-MC3-DMA 73.01  0.3 33.1  0.1
DOPE + 5%DLin-MC3-DMA 63.52  0.3 37.0  0.1
DOPE + 15%DLin-MC3-DMA 68.46  0.4 33.7  0.1
DOPC (pure) 69.00  1.2 35.6  0.1
DOPE (pure) 63.35  1.0 38.2  0.1
Fig. 4 Mass density profiles for the following systems: (a) DOPC and (b) DOPE. Labels: ‘‘Pure’’ stands for lipid bilayers containing only phospholipids, +5%
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DOPC is higher than that at 5 mol% of the amine lipid, while
for the system containing DOPE the mass density of water in
the bilayer center is almost equal to zero.
These findings suggest that there are two competing effects
which determine the water penetration in the investigated
membranes. The effects dominate in systems with DOPE and
DLin-MC3-DMA. At the lowest concentration of DLin-MC3-DMA
the peak of the mass density for the CH3-groups of the lipid
tails is observed inside the PO4-group region (Fig. 5(b)). This
location of small amounts of hydrophobic parts can be the reason
for a proton-transfer disruption, because in the pure phospholipid
bilayers the phosphate groups have ‘‘the proton-collecting
antenna effect’’ according to Brändén et al.79 and Yamashita
et al.80 Furthermore, water molecules around phosphatidylcholine
headgroups do not have the same preferential orientations as they
have around phosphatidylethanolamine headgroups.81 Therefore
the presence of extraneous CH3-groups can cause pore formation
in DOPE membranes more than in lipid bilayers with DOPC.
At 15 mol% in lipid bilayers with DOPC the water penetra-
tion gets slightly higher with the increase in the concentration
of the amine lipid. This is correlated with the fact that a small
amount of headgroups of DLin-MC3-DMA reside in the center
of the membrane composed of DOPC (Fig. 5(c)). These head-
groups can play the role of ‘‘transporters’’ of water molecules
through the membrane. In the lipid bilayer with DOPE contain-
ing the same amount of DLin-MC3-DMA the decrease in water
penetration can be explained by the slight change in the
location of the lipid tails of DLin-MC3-DMA. The maximum
of the mass density profile for the CH3-group of the amine lipid
shifted towards the carbonyl groups of DOPE which can give
rise to a hydrophobic layer in that region and prevent the water
from entering the membrane.
Fig. 5 Contributions to the mass density profiles: (a) DOPC and 5% of DLin-MC3-DMA, (b) DOPE and 5% of DLin-MC3-DMA, (c) DOPC and 15% of DLin-
MC3-DMA and (d) DOPE and 15% of DLin-MC3-DMA. Pink areas show the locations of the PO4 headgroups of the phospholipids. DLin-MC3-DMA (h) and
DLin-MC3-DMA (t) denote the headgroup and the tail of the lipid respectively. On the image representing the structure of DLin-MC3-DMA the parts
which were used in calculations of partial molecular mass densities are denoted by red circles. From the head group only the nitrogen and two carbons
were taken for calculations in order to get a ‘‘comparable’’ profile, while from tails carbons with hydrogens were taken for computations. From the
structure of phospholipids on the picture the PO4-groups were considered as the representatives of the lipid headgroups, while tails were denoted with
CH3-groups in the ends of tails. Parts of DLin-MC3-DMA were colored in a different way: light gray color – hydrogen, dark gray – carbon, blue –
nitrogen, and red – oxygen. Black dashed lines denote the points of maximum for the mass densities of PO4-groups. Lipids on top are visualized using
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This information about the contributions to the mass den-
sities from different parts of the molecules allows us to only
speculate that the slow lateral diffusion at higher concentra-
tions of the amine lipids can be related to strong interactions
and, perhaps, associations between the headgroups of phos-
pholipids and parts of DLin-MC3-DMA. Particularly, in mem-
branes with DOPE lipid tails of the amine lipid seem to
associate with phospholipid headgroups. To elucidate this,
we have calculated RDFs for correlations between different
groups of the two components.
3.2 Radial distribution functions
RDFs are important characteristics of intra- and intermolecular
associations which can occur in various systems. They can also
explain the locations of molecules and be related to forces
causing molecular motions. For the simulated bilayers inter-
molecular RDFs were of high interest.
From the computed mass density profiles and diffusion
coefficients we got indications for the fact that there could be
forces occurring between the lipid headgroups which could
‘‘help’’ the amine lipid to stay closer to the DOPE membrane’s
surface or help DLin-MC3-DMA to penetrate the bilayer with
DOPC. In order to validate this hypothesis RDFs between pairs
of atoms in lipid headgroups were calculated. Fig. 6 shows
such correlation functions. In (a) one can see a high peak at a
distance less than 2 Å for hydrogen atoms in the amine-group
of DOPE and the oxygen atom in the carbonyl group of DLin-
MC3-DMA. This peak indicates possible formation of a hydro-
gen bond between these lipid groups. For the system contain-
ing DOPC (in the same part of the figure) such RDFs were
calculated for the methyl hydrogens of the choline group. In
this case hydrogen bonding does not occur between chosen
pairs of atoms in DOPC and DLin-MC3-DMA. However, in the
case of DOPC, hydrogens from the glycerol group seem to
associate more with the carbonyl oxygen from DLin-MC3-
DMA (Fig. 6(b)) and for DOPE such association takes place
only at 15 mol% of amine lipid in the system.
Another considerable group of RDFs are RDFs between
carbonyl oxygens in phospholipid tails and hydrogens in the
headgroup of the amine lipid. Fig. S7(a) in the ESI† demon-
strates strong associations between hydrogens from the CH-
group of DLin-MC3-DMA and the carbonyl oxygens in the
phospholipids. However, this association is rather weak for
the system containing DOPE and 5% of the amine lipid.
Fig. S7(b–d) (ESI†) presents significant peaks for the pair of
atoms labeled as ‘‘b’’, ‘‘c’’ and ‘‘d’’, but taking into account the
chemical structure of DLin-MC3-DMA it can be concluded that
these peaks are likely consequence of the associations illu-
strated in Fig. S7(a) (ESI†) or even Fig. 6(a).
From computations for lipid headgroups follows that inter-
actions between them are not strong enough to be considered
as possible hydrogen bonding. This leaves a question about
Fig. 6 RDFs between pairs of atoms in phospholipid and DLin-MC3-DMA headgroups. (a) RDFs between oxygen from DLin-MC3-DMA and hydrogens
from the CH3-group of DOPC/hydrogens from the amine group of DOPE. (b) RDFs between oxygen from DLin-MC3-DMA and hydrogens from the CH2-
group of the glycerol group in DOPC/DOPE. Parts of the phospholipids were colored in the following way: cyan color – carbon, blue color – nitrogen,
yellow color – phosphorus, red color – oxygen, and gray color – hydrogen. Parts of DLin-MC3-DMA were colored in a different way: light gray color –
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possible strong associations involving lipid tails. RDFs between
lipid tails were calculated for all combinations of pairs of
atoms, but no significant peaks were observed. However, the
lipid tails of DLin-MC3-DMA were found to be associated with
the headgroups of DOPE. Fig. 7 shows RDFs between hydrogens
from amine and methyl groups of phospholipids and carbons
from the tails of the amine lipid. High peaks can be observed
for carbons on positions (b) and (c) at a distance of about 2.1 Å.
In the case of DOPC, RDFs between hydrogens in the methyl
groups and carbons on the DLin-MC3-DMA tails show peaks as
well, but the distance is shifted to about 2.5 Å and the peak
value is significantly lower.
The DOPC headgroup associates rather with tails of DLin-
MC3-DMA, through hydrogens in the CH2-group. Fig. S8 in
the ESI† demonstrates strong associations between hydrogens
from the CH2-group in DOPC and carbons in positions (b) and
(c) of DLin-MC3-DMA. In the case of DOPE the peak appears at
a distance of 3 Å, which can occur due to an association with
the NH3-group (Fig. 7).
RDFs between phospholipids and DLin-MC3-DMA give an
idea about associations between these compounds and unveil
the mechanisms of the proton transfer disruption in mem-
branes with DOPE and the amine lipid. However, there is still a
missing variable which could help to clarify the structures of
Fig. 7 RDFs between pairs of atoms in phospholipid headgroups and in the tail of DLin-MC3-DMA. (a) RDFs between carbons labeled as ‘‘a’’ in
DLin-MC3-DMA and hydrogens from the CH3-group of DOPC/hydrogens from the amine group of DOPE. (b) RDFs between carbons labeled as ‘‘b’’ in
DLin-MC3-DMA and hydrogens from the CH3-group of DOPC/hydrogens from the amine group of DOPE. (c) RDFs between carbons labeled as ‘‘c’’
in DLin-MC3-DMA and hydrogens from the CH3-group of DOPC/hydrogens from the amine group of DOPE. (d) RDFs between carbons labeled as ‘‘d’’ in
DLin-MC3-DMA and hydrogens from the CH3-group of DOPC/hydrogens from the amine group of DOPE. Parts of the phospholipids were colored in the
following way: cyan color – carbon, blue color – nitrogen, yellow color – phosphorus, red color – oxygen, and gray color – hydrogen. Parts of DLin-
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membranes. This variable is the association between the
amine lipids themselves. Fig. S9 in the ESI† demonstrates the
strongest associations between the headgroups of the amine
lipids which occur at distances of 2.4–3.4 Å. Comparing the
values of RDFs between the amine lipids with RDFs between
DLin-MC3-DMA and phospholipids it can be concluded that
the amine lipids have a stronger tendency of aggregating with
themselves than associating with DOPC or DOPE. The concen-
tration of DLin-MC3-DMA affects its aggregation as well: RDFs
have lower values at 15 mol% of the amine lipid than at 5 mol%
(Fig. S9 in the ESI†). The reason for higher values of RDFs at
the lower concentration of DLin-MC3-DMA is likely that the
function was normalized to the average density of the lipid
which is lower at 5 mol% than at 15 mol%, and therefore a
given correlation becomes less weighted at a higher concen-
tration of the amine lipid.
Finalizing this discussion we can conclude that there is
valuable information about interactions occurring in LNPs by
DLin-MC3-DMA and phospholipids. At 5 mol% of the amine
lipid there is a slight structural difference between membranes
with DOPC and DOPE, while at 15 mol% of DLin-MC3-DMA one
can see clear discrepancies in lipid bilayers formed by each
phospholipid together with the amine lipid. In membranes
with DOPE the structure of domains appears as a hydrophobic
net of DLin-MC3-DMA on the surface, which is formed by
strong head-to-head aggregations between the amine lipids,
weaker head-to-head associations between DOPE and DLin-
MC3-DMA and relatively strong associations between the tails
of the amine lipid and the DOPE headgroup. In the case of lipid
bilayers with DOPC one can probably observe a ‘‘mixture’’ of
different domains, where the amine lipids can be partitioned
even in the center of the membrane.
3.3 Well-tempered metadynamics simulations
The resulting averaged and symmetrized potential of mean
force (PMF) profiles are presented in Fig. 8. During the integra-
tion of files the minimum of each PMF was set to zero, which is
seen on profiles as the area for the location of the water layer.
The curve representing PMF for the lipid bilayer containing
DOPE and 5% of DLin-MC3-DMA has the lowest free energy
value in the bilayer center among all, which can imply that
water will more likely penetrate this membrane than other
ones. The highest values of PMF are observed for the mem-
branes containing DOPC with 5% of DLin-MC3-DMA and DOPE
with 15% of DLin-MC3-DMA, which could mean that these two
lipid bilayers are least permeable.
However, regardless of the fact that PMF can visualize the
thermodynamics of a process very well, the actual value of
the free energy can give more idea about the possibility for the
process to proceed spontaneously. In the case of simulated
systems the binding free energy value is the thermodynamic
characteristics, which is showing if the process of water pene-
tration through a membrane can go spontaneously. It can be
computed according to the following eqn (7):








here B denotes the ‘‘bound’’ state, U is the ‘‘unbound’’ state
(see Fig. 8), kB is the Boltzmann constant, b = 1/(kBT), z is the
CV, and T is the temperature in K.
Table 4 shows binding free energies for a water molecule in
all simulated systems. All integrals were calculated according to
mass density profiles determined from the analysis of classical
MD simulations (‘‘bound’’ and ‘‘unbound’’ states). From the
energetic point of view the lipid bilayer containing DOPE and
5% of DLin-MC3-DMA appears to be the most permeable, while
all other membranes seem to be the least permeable from the
similarity of PMF profiles and values of binding free energies.
These findings are coherent with observations from classical
MD simulations where the water penetration through mem-
branes was detected from mass density profiles (Fig. S10–S17
presenting the information about the evolution of CVs and
convergence are shown in the ESI.†)
Fig. 8 Averaged potential of mean force (PMF) profiles for 4 lipid bilayers. Values of PMF in the bilayer center demonstrate which membrane water
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Nevertheless, for proper investigations of the water penetra-
tion through a membrane the free energy is not the only factor
which shall be taken into consideration: characteristics such as
the diffusion of water molecules inside the bilayers and the
membrane thicknesses82,83 are of importance. Although the
latter ones can be determined, computation of diffusion for a
single water molecule is rather a complex process. The reason is
the differences in diffusion of water in various locations in
systems (in water, by the membrane surface, between lipid tails
or in the center of the membrane) and the compositions of the
lipid bilayers.83 Therefore, we provide only thermodynamic
characteristics of the water penetration process in this work.
4 Conclusions
In this work a neutral model for the amine lipid was derived
and the atomistic MD simulations were carried out employing
the new model.
Regardless of the fact that our membranes were very simple
they still give the information about certain domains formed in
the shell of complex LNPs.11,84 Taking into consideration the
structural information obtained from computed properties one
can conclude that the amine lipid forms aggregates in DOPC
lipid bilayers at a concentration of 15 mol% of DLin-MC3-DMA,
while at the same concentration in DOPE the structures create
hydrophobic nets on the surface of the membrane: between the
phosphate and carbonyl groups of DOPE. These nets are in the
case of our simulations seen as causes of a slow lateral diffu-
sion at higher concentrations of the amine lipid and the pore
formation in the DOPE membrane with the lowest content of
DLin-MC3-DMA, probably, due to the proton transfer disrup-
tion around the phospholipid headgroups.79–81 However,
regarding the proton transfer disruption we can only speculate
out of scientific findings made by those who investigated
similar problems using experimental or computational meth-
ods. It can be concluded that such a behavior of DLin-MC3-
DMA in membranes with DOPE can be the reason why LNPs
composed of these lipids have bad transfection properties.17
Nevertheless, considering only the fusogenic properties of
LNPs might not be the best approach, because these vehicles
interact with cell membranes which might have ‘‘incompati-
ble’’ fusogenic properties. According to Sayers et al.85 one shall
investigate the properties of cell membranes when working on
the delivery of nucleic acids. Moreover employing more than
one helper lipid in LNPs can also improve their properties.
Epaxals86,87 for treating hepatitis A and Inflexal Vs88,89 for
treating an influenza were developed and approved in the end
of the twentieth century. Both drugs are known to be based on a
mixture of DOPC and DOPE.90 MD simulations of lipid bilayers
containing more than one helper lipid together with the amine
lipid are considered for the future work together with more
complex systems.
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